Cambrex (CBM) Gross Profit Margin starting from the third quarter 2019 to third quarter 2018, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Cambrex Corp  (CBM)


Cambrex's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBM Gross Profit Margin (Sep 30 2019)
Q3 		(Jun 30 2019)
Q2 		(Mar 31 2019)
Q1 		(Dec 31 2018)
Q4 		(Sep 30 2018)
Q3
Y / Y Revenue Change 42.01 %
Seq. Revenue Change -15.99 %
Revenue In Millions $148.56
Gross Profit Margin 34.26 %
Gross Profit Margin Total Ranking # 2588
Gross Profit In Millions $50.90
Y / Y Gross Profit Change 55.54 %
Seq. Gross Profit Change -18.98 %


Commenting Third Quarter 2019 Gross Profit Margin
Cambrex Corp experienced contraction in Gross Profit by -18.98 % to $149 millions and Revenue by -15.99 %, while Gross Profit Margin fell to 34.26 %, below company*s average Gross Profit Margin.


Observing third quarter 2019 results within Major Pharmaceutical Preparations industry 139 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2588, from total ranking in the previous quarter at 2646.
Learn about Gross Margin
CBM's Gross Profit Margin third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 140
Healthcare Sector # 393
Overall # 2503

Gross Profit Margin Statistics
High Average Low
44.59 % 36.54 % 25.08 %
(Mar 31 2017)   (Mar 31 2014)


CBM Gross Income Trends • More of CBM's Profitabilty Ratios • CBM Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CBM's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CBM's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CBM's Competitors
Gross Profit Margin Profit Margin for Cambrex's Suppliers
Gross Profit Margin Profit Margin for CBM's Customers

You may also want to know
CBM's Annual Growth Rates CBM's Profitability Ratios CBM's Asset Turnover Ratio CBM's Dividend Growth
CBM's Roe CBM's Valuation Ratios CBM's Financial Strength Ratios CBM's Gross Profit Growth
CBM's Roa CBM's Inventory Turnover Ratio CBM's Growth Rates CBM's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2019 MRQ Gross ProfitSep 30 2019 MRQ Revenue
Therapeuticsmd Inc   93.91 %$ 22.275  Millions$ 23.720  Millions
Adamas Pharmaceuticals Inc  93.33 %$ 13.004  Millions$ 13.933  Millions
Durect Corp  93.21 %$ 10.032  Millions$ 10.763  Millions
Portola Pharmaceuticals inc   92.71 %$ 34.115  Millions$ 36.799  Millions
Alnylam Pharmaceuticals Inc   92.56 %$ 64.848  Millions$ 70.061  Millions
Pfenex Inc   92.50 %$ 14.105  Millions$ 15.248  Millions
Alexion Pharmaceuticals Inc   92.46 %$ 1,167.900  Millions$ 1,263.100  Millions
Karyopharm Therapeutics Inc   92.30 %$ 12.136  Millions$ 13.149  Millions
Stemline Therapeutics Inc  91.96 %$ 12.261  Millions$ 13.333  Millions
United Therapeutics Corporation  91.78 %$ 368.500  Millions$ 401.500  Millions
Zevra Therapeutics Inc   91.28 %$ 10.463  Millions$ 11.463  Millions
Gw Pharmaceuticals Plc  91.04 %$ 82.821  Millions$ 90.971  Millions
Siga Technologies Inc  90.91 %$ 7.374  Millions$ 8.111  Millions
Siga Technologies Inc  90.91 %$ 7.374  Millions$ 8.111  Millions
Ultragenyx Pharmaceutical Inc   89.60 %$ 23.117  Millions$ 25.800  Millions
Optinose Inc   88.80 %$ 11.008  Millions$ 12.397  Millions
Vanda Pharmaceuticals Inc   88.60 %$ 52.703  Millions$ 59.485  Millions
Amicus Therapeutics inc   88.53 %$ 43.172  Millions$ 48.768  Millions
Akcea Therapeutics Inc   88.36 %$ 18.223  Millions$ 20.624  Millions
Serina Therapeutics Inc   88.08 %$ 0.362  Millions$ 0.411  Millions
Lexaria Bioscience Corp   88.05 %$ 0.110  Millions$ 0.125  Millions
Alimera Sciences Inc  87.71 %$ 11.271  Millions$ 12.850  Millions
Mannkind Corporation  87.42 %$ 12.759  Millions$ 14.595  Millions
Kindred Biosciences Inc   87.41 %$ 0.965  Millions$ 1.104  Millions
Flexion Therapeutics Inc   86.82 %$ 18.914  Millions$ 21.786  Millions
Vertex Pharmaceuticals Inc  86.11 %$ 817.914  Millions$ 949.828  Millions
Lannett Company Inc  85.86 %$ 42.658  Millions$ 49.686  Millions
Catalyst Pharmaceuticals Inc   85.80 %$ 26.510  Millions$ 30.897  Millions
Health right Discoveries Inc   84.59 %$ 0.701  Millions$ 0.828  Millions
Zyla Life Sciences  84.38 %$ 18.889  Millions$ 22.386  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.